Systematic whole-genome or exome sequencing of prostate tumors has led to the identification of frequent somatic mutations in SPOP (Barbieri et al., 2012; Berger et al., 2011; Grasso et al., 2012; Kan et al., 2010). This evidence concerns the gene SPOP and prostate neoplasm.